Literature DB >> 21321182

Optimal duration of anticoagulation after venous thromboembolism.

Samuel Z Goldhaber1, Gregory Piazza.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21321182      PMCID： PMC3074464          DOI： 10.1161/CIRCULATIONAHA.110.970822

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  21 in total

1.  Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model.

Authors:  Sabine Eichinger; Georg Heinze; Lisanne M Jandeck; Paul A Kyrle
Journal:  Circulation       Date:  2010-03-29       Impact factor: 29.690

2.  Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study.

Authors:  J A Heit; D N Mohr; M D Silverstein; T M Petterson; W M O'Fallon; L J Melton
Journal:  Arch Intern Med       Date:  2000-03-27

3.  High-density lipoprotein and the risk of recurrent venous thromboembolism.

Authors:  Sabine Eichinger; Natalie M Pecheniuk; Gregor Hron; Hiroshi Deguchi; Michael Schemper; Paul A Kyrle; John H Griffin
Journal:  Circulation       Date:  2007-03-19       Impact factor: 29.690

4.  The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.

Authors:  Paolo Prandoni; Franco Noventa; Angelo Ghirarduzzi; Vittorio Pengo; Enrico Bernardi; Raffaele Pesavento; Matteo Iotti; Daniela Tormene; Paolo Simioni; Antonio Pagnan
Journal:  Haematologica       Date:  2007-02       Impact factor: 9.941

5.  Elevated D-dimer levels predict recurrence in patients with idiopathic venous thromboembolism: a meta-analysis.

Authors:  E Bruinstroop; F A Klok; M A Van De Ree; F L Oosterwijk; M V Huisman
Journal:  J Thromb Haemost       Date:  2009-01-19       Impact factor: 5.824

6.  Overweight, obesity, and the risk of recurrent venous thromboembolism.

Authors:  Sabine Eichinger; Gregor Hron; Christine Bialonczyk; Mirko Hirschl; Erich Minar; Oswald Wagner; Georg Heinze; Paul A Kyrle
Journal:  Arch Intern Med       Date:  2008-08-11

7.  Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Clive Kearon; Susan R Kahn; Giancarlo Agnelli; Samuel Goldhaber; Gary E Raskob; Anthony J Comerota
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

Review 8.  Venous thromboembolism: risk factors for recurrence.

Authors:  Tienan Zhu; Isabelle Martinez; Joseph Emmerich
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-03       Impact factor: 8.311

9.  Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.

Authors:  Paolo Prandoni; Anthonie W A Lensing; Andrea Piccioli; Enrico Bernardi; Paolo Simioni; Bruno Girolami; Antonio Marchiori; Paola Sabbion; Martin H Prins; Franco Noventa; Antonio Girolami
Journal:  Blood       Date:  2002-07-12       Impact factor: 22.113

10.  Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial.

Authors:  Paolo Prandoni; Martin H Prins; Anthonie W A Lensing; Angelo Ghirarduzzi; Walter Ageno; Davide Imberti; Gianluigi Scannapieco; Giovanni B Ambrosio; Raffaele Pesavento; Stefano Cuppini; Roberto Quintavalla; Giancarlo Agnelli
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391
View more
  3 in total

1.  Emergency department ultrasound diagnosis of spontaneous iliopsoas haemorrhage in a patient on warfarin.

Authors:  Devesh Sharma; Ramy Saker; Abha Govind
Journal:  BMJ Case Rep       Date:  2013-11-15

2.  Impact of Provoking Risk Factors on the Prognosis of Cerebral Venous Thrombosis in Korean Patients.

Authors:  Eun-Jae Lee; Sang-Mi Noh; Dong-Wha Kang; Jong S Kim; Sun U Kwon
Journal:  J Stroke       Date:  2016-05-10       Impact factor: 6.967

3.  Should lifelong anticoagulation for unprovoked venous thromboembolism be revisited?

Authors:  Otto Moodley; Hadi Goubran
Journal:  Thromb J       Date:  2015-10-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.